Terug
Dagbereik
€ 51,60
€ 56,95
52-Weeksbereik
€ 49,00
€ 65,44
Volume
2
50D / 200D Gem.
€ 62,38
/
€ 64,68
Vorige Slotkoers
€ 56,95
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 27,9 | 0,4 |
| P/B | 6,2 | 2,9 |
| ROE % | 23,4 | 3,8 |
| Net Margin % | 17,8 | 3,9 |
| Rev Growth 5Y % | 12,8 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 5,38
€ 5,21 – € 5,51
|
3,7 B | 1 |
| FY2029 |
€ 4,55
€ 4,41 – € 4,67
|
3,5 B | 1 |
| FY2028 |
€ 4,06
€ 3,93 – € 4,16
|
3,2 B | 1 |
Belangrijkste Punten
Revenue grew 12,75% annually over 5 years — strong growth
ROE of 23,38% indicates high profitability
Net margin of 17,79% shows strong profitability
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -281,24M
Capital intensive — 36,35% of revenue goes to capex
Groei
Revenue Growth (5Y)
12,75%
Revenue (1Y)12,45%
Earnings (1Y)7,01%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
23,38%
ROIC25,22%
Net Margin17,79%
Op. Margin27,28%
Veiligheid
Debt / Equity
0,01
Current Ratio1,61
Interest Coverage7,83
Waardering
P/E Ratio
27,87
P/B Ratio6,19
EV/EBITDA17,70
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,45% | Revenue Growth (3Y) | 12,40% |
| Earnings Growth (1Y) | 7,01% | Earnings Growth (3Y) | 15,48% |
| Revenue Growth (5Y) | 12,75% | Earnings Growth (5Y) | 4,08% |
| Profitability | |||
| Revenue (TTM) | 2,34B | Net Income (TTM) | 416,51M |
| ROE | 23,38% | ROA | 8,11% |
| Gross Margin | 68,34% | Operating Margin | 27,28% |
| Net Margin | 17,79% | Free Cash Flow (TTM) | -281,24M |
| ROIC | 25,22% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 1,61 |
| Interest Coverage | 7,83 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 27,87 | P/B Ratio | 6,19 |
| P/S Ratio | 4,96 | PEG Ratio | 3,09 |
| EV/EBITDA | 17,70 | Dividend Yield | 0,02% |
| Market Cap | 11,61B | Enterprise Value | 11,31B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 2,34B | 2,08B | 1,85B | 1,58B | 1,45B |
| Net Income | 416,51M | 389,21M | 312,34M | 385,97M | 354,98M |
| EPS (Diluted) | 1,99 | 1,86 | 1,49 | 1,85 | 1,70 |
| Gross Profit | 1,60B | 1,48B | 1,29B | 1,15B | 1,04B |
| Operating Income | 638,86M | 558,01M | 437,33M | 490,19M | 469,02M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 5,13B | 4,21B | 4,00B | 2,82B | 2,71B |
| Total Liabilities | 3,26B | 2,52B | 2,45B | 1,43B | 1,44B |
| Shareholders' Equity | 1,88B | 1,69B | 1,55B | 1,38B | 1,28B |
| Total Debt | 22,85M | 99,93M | 1,72B | 992,19M | 1,06B |
| Cash & Equivalents | 322,42M | 221,81M | 284,73M | 244,58M | 188,23M |
| Current Assets | 1,49B | 1,20B | 1,19B | 850,10M | 772,95M |
| Current Liabilities | 929,06M | 1,00B | 923,74M | 626,42M | 578,46M |